# ESMO Open

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/esmo-open/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 3,290 |
| Citations | 55,351 |
| h-index | 97 |
| Homepage | https://www.journals.elsevier.com/esmo-open |
| Open Access | true |
| ISSN-L | 2059-7029 |
| ISSNs | 2059-7029 |
| OpenAlex ID | https://openalex.org/S4210217024 |
| Publisher | Elsevier BV |
| Works | 8,331 |

## Journal papers

Showing 12 of 18.

- [Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment](https://scholariq.org/papers/drug-induced-interstitial-lung-disease-during-cancer-therapies-expert-opinion-on/)
- [The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies](https://scholariq.org/papers/the-molecular-profiling-of-solid-tumors-by-liquid-biopsy-a-position-paper-of-the/)
- [Pan-Asian adaptation of the EHNS–ESMO–ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck](https://scholariq.org/papers/pan-asian-adaptation-of-the-ehns-esmo-estro-clinical-practice-guidelines-for-the/)
- [Multidisciplinary clinical guidelines in proactive monitoring, early diagnosis, and effective management of trastuzumab deruxtecan (T-DXd)-induced interstitial lung disease (ILD) in breast cancer patients](https://scholariq.org/papers/multidisciplinary-clinical-guidelines-in-proactive-monitoring-early-diagnosis/)
- [Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis](https://scholariq.org/papers/impact-of-solid-cancer-on-in-hospital-mortality-overall-and-among-different/)
- [Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma](https://scholariq.org/papers/phase-iii-study-of-gefitinib-or-pemetrexed-with-carboplatin-in-egfr-mutated/)
- [Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancer](https://scholariq.org/papers/cell-free-dna-from-bile-outperformed-plasma-as-a-potential-alternative-to-tissue/)
- [Management of infusion-related reactions in cancer therapy: strategies and challenges](https://scholariq.org/papers/management-of-infusion-related-reactions-in-cancer-therapy-strategies-and/)
- [Impact of the combined timing of PD-1/PD-L1 inhibitors and chemotherapy on the outcomes in patients with refractory lung cancer](https://scholariq.org/papers/impact-of-the-combined-timing-of-pd-1-pd-l1-inhibitors-and-chemotherapy-on-the/)
- [Patient-reported pain severity, pain interference and health status in HR+/HER2− advanced/metastatic breast cancer](https://scholariq.org/papers/patient-reported-pain-severity-pain-interference-and-health-status-in-hr-her2/)
- [Maintenance therapy with a poly(ADP-ribose) polymerase inhibitor in patients with newly diagnosed advanced epithelial ovarian cancer: individual patient data and trial-level meta-analysis](https://scholariq.org/papers/maintenance-therapy-with-a-poly-adp-ribose-polymerase-inhibitor-in-patients-with/)
- [Clinical utility of comprehensive circulating tumor DNA genotyping compared with standard of care tissue testing in patients with newly diagnosed metastatic colorectal cancer](https://scholariq.org/papers/clinical-utility-of-comprehensive-circulating-tumor-dna-genotyping-compared-with/)

## Journal top topics

Showing 8 of 25.

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.